CR9523A - Tableta recubierta de azucar - Google Patents

Tableta recubierta de azucar

Info

Publication number
CR9523A
CR9523A CR9523A CR9523A CR9523A CR 9523 A CR9523 A CR 9523A CR 9523 A CR9523 A CR 9523A CR 9523 A CR9523 A CR 9523A CR 9523 A CR9523 A CR 9523A
Authority
CR
Costa Rica
Prior art keywords
sugar
covered tablet
oxygen
active ingredient
tablet
Prior art date
Application number
CR9523A
Other languages
English (en)
Inventor
Uchiyama Yoshihiro
Nakano Yoshinori
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37498554&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR9523(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of CR9523A publication Critical patent/CR9523A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe una preparacion en donde un ingrediente activo inestable al oxigeno es estabilizado por un recubrimiento de una porcion que contiene el ingrediente activo inestable al oxigeno con una capa de recubrimiento con azucar que contiene alcohol de azucar como material base de recubrimiento con azucar y un aglutinante.
CR9523A 2005-06-10 2007-11-15 Tableta recubierta de azucar CR9523A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005171443 2005-06-10

Publications (1)

Publication Number Publication Date
CR9523A true CR9523A (es) 2008-02-04

Family

ID=37498554

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9523A CR9523A (es) 2005-06-10 2007-11-15 Tableta recubierta de azucar

Country Status (19)

Country Link
US (1) US20090030064A1 (es)
EP (1) EP1889611A1 (es)
JP (1) JPWO2006132360A1 (es)
KR (1) KR20080014014A (es)
CN (1) CN101193625A (es)
AR (1) AR054133A1 (es)
AU (1) AU2006256038A1 (es)
BR (1) BRPI0611058A2 (es)
CA (1) CA2610342A1 (es)
CR (1) CR9523A (es)
IL (1) IL187407A0 (es)
MA (1) MA29540B1 (es)
NO (1) NO20080175L (es)
NZ (1) NZ563820A (es)
PE (1) PE20070077A1 (es)
RU (1) RU2407515C2 (es)
TW (1) TW200716207A (es)
WO (1) WO2006132360A1 (es)
ZA (1) ZA200710333B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009101940A1 (ja) * 2008-02-11 2009-08-20 Dainippon Sumitomo Pharma Co., Ltd. 溶出性の改善された錠剤
TW201021832A (en) * 2008-09-30 2010-06-16 Astellas Pharma Inc Pharmaceutical composition for oral administration
JPWO2011027728A1 (ja) * 2009-09-02 2013-02-04 日本曹達株式会社 ヒドロキシアルキルセルロースを含むコーティング剤
CN101804042A (zh) * 2010-04-16 2010-08-18 山东新华制药股份有限公司 普拉格雷片剂的制备方法
US10251194B2 (en) * 2013-06-17 2019-04-02 Nxp Usa, Inc. Efficient scheduling in asynchronous contention-based system
FR3013186B1 (fr) * 2013-11-19 2019-07-19 Roquette Freres Nouveaux snacks non allergenes contenant des proteines vegetales
CN103977427A (zh) * 2014-05-08 2014-08-13 王�琦 一种糖衣产气粉配方及其制备方法
FR3067567B1 (fr) * 2017-06-19 2019-07-05 Roquette Freres Nouveau procede de drageification et formes solides drageifiees presentant des formes irregulieres
FR3089756B1 (fr) * 2018-12-17 2021-02-19 Roquette Freres Formes solides dragéifiées présentant une stabilité améliorée
JP7503420B2 (ja) * 2020-05-18 2024-06-20 東和薬品株式会社 フィンゴリモドを含む医薬組成物とその製造方法及び安定化方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1168082A (en) * 1979-10-17 1984-05-29 Francis Devos Hard coating process with sorbitol and products so-obtained
JPH0816052B2 (ja) * 1988-11-21 1996-02-21 エスエス製薬株式会社 糖衣錠
JP3507211B2 (ja) * 1995-07-13 2004-03-15 三菱化学株式会社 糖衣液及び糖衣錠
PT1136477E (pt) * 1998-12-04 2004-08-31 Takeda Chemical Industries Ltd Derivados do benzofurano processo para a sua preparacao e suas utilizacoes
JP2001139495A (ja) * 1999-11-19 2001-05-22 Shin Etsu Chem Co Ltd フィルムコーティング剤及び経口固形製剤
AT500063A1 (de) * 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
JP2002047174A (ja) * 2000-05-26 2002-02-12 Towa Chem Ind Co Ltd 無糖コーティング製剤及びその製造方法
DE10033023A1 (de) * 2000-07-07 2002-01-31 Biogrund Gmbh Filmüberzugszusammensetzung auf Basis von Zellulosederivaten und Zuckeralkoholen
JP2002179559A (ja) * 2000-10-06 2002-06-26 Takeda Chem Ind Ltd 薄層糖衣錠およびその製造方法
JP4824224B2 (ja) * 2001-08-28 2011-11-30 興和株式会社 糖衣製剤
JP2003095928A (ja) * 2001-09-27 2003-04-03 Kowa Co 糖衣製剤
JP2003113060A (ja) * 2001-10-02 2003-04-18 Lion Corp 発泡成分含有糖衣物
JP4336074B2 (ja) * 2001-11-15 2009-09-30 三菱商事フードテック株式会社 色調および食感が良好な硬質糖衣錠剤
US20050118202A1 (en) * 2001-12-19 2005-06-02 Akio Yamashita Solid compositions containing compounds unstable to oxygen and method for stabilization thereof
JP4590034B2 (ja) * 2002-01-31 2010-12-01 三菱商事フードテック株式会社 硬質糖衣製剤、糖衣液及び硬質糖衣製剤の製造方法
JP2004123578A (ja) * 2002-09-30 2004-04-22 Dainippon Ink & Chem Inc 糖衣錠およびその製造方法
JP2005298373A (ja) * 2004-04-08 2005-10-27 Kyowa Hakko Kogyo Co Ltd 吸水性アミノ酸含有糖衣錠剤
JP4984455B2 (ja) * 2004-08-18 2012-07-25 日本新薬株式会社 二重被覆錠剤

Also Published As

Publication number Publication date
AU2006256038A1 (en) 2006-12-14
KR20080014014A (ko) 2008-02-13
BRPI0611058A2 (pt) 2011-02-22
JPWO2006132360A1 (ja) 2009-01-08
EP1889611A1 (en) 2008-02-20
WO2006132360A1 (ja) 2006-12-14
CN101193625A (zh) 2008-06-04
NZ563820A (en) 2010-03-26
TW200716207A (en) 2007-05-01
RU2007145426A (ru) 2009-06-20
CA2610342A1 (en) 2006-12-14
PE20070077A1 (es) 2007-02-07
ZA200710333B (en) 2009-03-25
RU2407515C2 (ru) 2010-12-27
MA29540B1 (fr) 2008-06-02
NO20080175L (no) 2008-03-04
US20090030064A1 (en) 2009-01-29
IL187407A0 (en) 2008-02-09
AR054133A1 (es) 2007-06-06

Similar Documents

Publication Publication Date Title
AR068369A1 (es) Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina"
AR114143A2 (es) Formulaciones de comprimidos revestidos
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
CL2007002218A1 (es) Uso de 3-(4-amino-1-oxo-1,3-dihidro-isoindol-2-il)-piperidina 2,6-diona para la preparacion de un medicamento util para el tratamiento de linfoma de celula de capa.
CL2011000935A1 (es) Composicion farmaceutica que comprende acetaminofeno y un material de tramadol complejo, que exhibe una liberacion sostenida y coordinada a traves de una capa de liberacion sostenida y otra de liberacion inmediata; metodo de preparacion;y el uso de un material complejo de tramadol y acetaminofeno para preparar un medicamento para el tratamiento del dolor.
BRPI0815709A2 (pt) composro, composição farmacêutica, e, uso de um composto.
BRPI0716171A2 (pt) composto, composiÇço farmacÊutica e uso de um composto.
CR8845S (es) Recipiente cubierto
DK1876897T3 (da) Aktivstofkombinationer
CL2007002316A1 (es) Compuestos derivados de pirimidina, inhibidores de pi3k; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en enfermedades proliferativas como cancer.
CR11581A (es) Composiciones en forma de comprimidos bucodispersables de temazepan
BRPI0908208A2 (pt) Composto derivado de oxazolidinona, medicamento, composição farmacêutica que o contém e uso desse composto.
CL2009000004A1 (es) Forma cristalina de r-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida; composicion farmaceutica que comprende a dicha forma cristalina; y uso para el tratamiento de diabetes o hiperglicemia.
BRPI0907892A2 (pt) Composto antibiótico azatricíclico, medicamento, composição farmacêutica que o contém e uso do mesmo
EA201200484A1 (ru) Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином
DE602005007488D1 (de) Zusammensetzung mit interkalierten funktionell aktiven organischen verbindungen
CR8683S (es) Recipiente cubierto para comida
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
CL2013000154A1 (es) Material compuesto polimerico con funcionalidad biocida que comprende una capa de soporte y una capa con un ingrediente activo biocida; su procedimiento produccion de dicho compuesto; y uso de dicho material en agricultura y/ u horticultura; y peliculas que comprenden a dicho material.
CL2009000665A1 (es) Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas.
NO20080175L (no) Sukkerbelagt tablett
EP2071555A4 (en) ACTIVE MATRIX SUBSTRATE
BRPI0720684A2 (pt) composto, medicamento, composição farmacêutica que contém e uso do composto
UY28987A1 (es) Cuerpos de moldeo solidos que contienen sustancia activa para el uso externo frente a parasitos en animales
BRPI0908577A2 (pt) preparação farmacêutica estável por longo tempo com a substância ativa trinitrato de glicerol

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)